Innovations 2018 en néphrologie : Transplantation rénale ABO incompatible par rein de donneur vivant

Mourad, Michel;Kanaan, Nada
(2019) Louvain médical — Vol. 138, n° 2, p. 110-111 (2019)

Files

2019_LM_Innovations_Néprologie_Abstract.pdf
  • Open Access
  • Adobe PDF
  • 127.84 KB
Download
2019_LM_Innovations_Néprologie.pdf
  • Restricted Access
  • Adobe PDF
  • 79.01 KB
Request a copy

Details

Authors
  • Mourad, MichelUCLouvain
    Author
  • Kanaan, NadaUCLouvain
    Author
Abstract
(en) [Innovations in Nephrolgy in 2018] This article reviews innovations in kidney transplantation, particularly in terms of cutaneous carcinomas and ABO incompatibility. Kidney transplant recipients are at risk of developing basal cell or squamous cell carcinomas due to immunosuppression induced by anti-rejection therapy. A multidisciplinary approach to these skin lesions is required to optimize the therapeutic management, thereby improving patient prognosis. Kidney transplantation from ABO-incompatible living donor patients was introduced in 1982 and successfully taken up in our institution last year. It is rendered possible due to a strategy combining desensitization of the recipient and reinforced immunosuppression. Survival of patients and grafts appears to be equivalent to that observed in ABO compatible transplant patients.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Mourad, M., & Kanaan, N. (2019). Innovations 2018 en néphrologie : Transplantation rénale ABO incompatible par rein de donneur vivant. Louvain médical, 138(2), 110-111. https://hdl.handle.net/2078.5/92751 (Original work published 2019)